Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 17, Issue 5, 2005, Pages 353-356

  Salomon, Laurent J ^a   Rozenberg, Patrick ^a   Szekeres Bartho, Julia ^b   Malagrida, Lydia ^a   Giudicelli, Yves ^a   Ville, Yves ^a,c  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b UNIVERSITY OF PÉCS   (Hungary)

^c CENTRE HOSPITALIER INTERCOMMUNAL   (France)

Author keywords

Abortion; Elective pregnancy termination; Immunosuppression; Mifeprestone; Progesterone

Indexed keywords

ANTIGESTAGEN; MIFEPRISTONE; PROGESTERONE; PROTEIN PROGESTERONE INDUCED BLOCKING FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HUMAN; IMMUNE DEFICIENCY; IMMUNOCYTOCHEMISTRY; PERIPHERAL LYMPHOCYTE; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VENOUS BLOOD;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, ORAL; ADULT; FEMALE; HUMANS; LYMPHOCYTES; MIFEPRISTONE; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; SUPPRESSOR FACTORS, IMMUNOLOGIC;

EID: 22244448087     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/14767050500140370     Document Type: Article

References (24)

1. Chaouat G, Kolb JP, Wegmann, TG. The murine placenta as an immunological barrier between the mother and the fetus. Immunol Rev 1983;75:31-60.
2. Szekeres-Bartho J. Endocrine regulation of the immune system during pregnancy. Arch Immunol Ther Exp (Warsz) 1990;38(1-2):125-140.
3. Szekeres-Bartho J, Szekeres G, Debre P, et al. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol 1990;125(2):273-283.
4. Szekeres-Bartho J, Kilar F, Falkay G, et al. The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol 1985;9(1):15-18.
5. Szekeres-Bartho J, Chaouat G. Lymphocyte-derived progesterone-induced blocking factor corrects resorption in a murine abortion system. Am J Reprod Immunol 1990;23(1):26-28.
6. Szekeres-Bartho J, Kinsky R, Chaouat G. The effect of a progesterone-induced immunologic blocking factor on NK-mediated resorption. Am J Reprod Immunol 1990;24(4):105-107.
7. Szekeres-Bartho J, Faust Z, Varga P. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol 1995;34(6):342-348.
8. Szekeres-Bartho J, Par G, Szereday L, et al. Progesterone and non-specific immunologic mechanisms in pregnancy. Am J Reprod Immunol 1997;38(3):176-182.
9. Szekeres-Bartho J, Barakonyi A, Par G, et al. Progesterone as an immunomodulatory molecule. Int Immunopharmacol 2001;1(6):1037-1048.
10. Szekeres-Bartho J, Faust Z, Varga P, et al. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996;35(4):348-351.
11. Faust Z, Laskarin G, Rukavina D, et al. Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am J Reprod Immunol 1999;42(2):71-75.
12. Szereday L, Varga P, Szekeres-Bartho J. Cytokine production by lymphocytes in pregnancy. Am J Reprod Immunol 1997;38(6):418-422.
13. Par G, Bartok B, Szekeres-Bartho J. Cyclooxygenase is involved in the effects of progesterone-induced blocking factor on the production of interleukin 12. Am J Obstet Gynecol 2000;183(1):126-130.
14. Szekeres-Bartho J, Wegmann TG. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 1996;31(1-2):81-95.
15. Peyron R, Aubeny E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993;328(21): 1509-1513.
16. Szekeres-Bartho J, Philibert D, Chaouat G. Progesterone suppression of pregnancy lymphocytes is not mediated by glucocorticoid effect. Am J Reprod Immunol 1990;23(2):42-43.
17. Szekeres-Bartho J, Autran B, Debre P, et al. Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 1989;122(2):281-294.
18. Szekeres-Bartho J, Chaouat G, Kinsky R. A progesterone-induced blocking factor corrects high resorption rates in mice treated with antiprogesterone. Am J Obstet Gynecol 1990;163(4 Pt 1):1320-1322.
19. Szekeres-Bartho J, Par G, Dombay G, et al. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity. Cell Immunol 1997;177(2):194-199.
20. Spitz IM, Bardin CW, Benton L, et al. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338(18):1241-1247.
21. Herrmann W, Wyss R, Riondel A, et al. The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy. C R Seances Acad Sci III 1982;294(18):933-938.
22. Check JH, Ostrzenski A, Klimek R. Expression of an immunomodulatory protein known as progesterone induced blocking factor (PIBF) does not correlate with first trimester spontaneous abortions in progesterone supplemented women. Am J Reprod Immunol 1997;37(4):330-334.
23. Szekeres-Bartho J, Varga P, Pacsa AS. Immunologic factors contributing to the initiation of labor-lymphocyte reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol 1986;155(1):108-112.
24. Szekeres-Bartho J, Szabo J, Kovacs L. Alteration of lymphocyte reactivity in pregnant women treated with the progesterone receptor inhibitor ZK 98734. Am J Reprod Immunol 1989;21(2):46-49.